
Researchers utilized untargeted reverse-phase liquid chromatography-mass spectrometry (RPLC-MS) to analyze serum metabolite profiles under normal and sleep-restricted conditions. The RPLC-MS analysis successfully identified 90 circulating metabolites—including 14 of microbial origin—and demonstrated that sleep deprivation significantly disrupts the natural rhythmic cycles of these host and microbial compounds. These findings indicate that microbial metabolites detected via RPLC-MS could potentially serve as clinical biomarkers for the various health and metabolic risks associated with sleep loss.




























